Valpam 5 (diazepam) tablets recalled because of suspected tampering

9 June 2017

A recall notice has been issued for all packs of Valpam 5 (diazepam) following the discovery of potential tampering, which has been reported to the police.

As a precautionary measure, in the interests of public health and safety, Arrow Pharma Pty Ltd in consultation with the TGA, is recalling all batches of Valpam 5 tablets supplied in blister packs of 50 tablets, as some blister packs have been found to contain Sandoz Amlodipine 5mg tablets. This product is also subject to a consumer level recall for the one affected batch.

This recall follows a similar recall two weeks ago by Roche Products, in consultation with the TGA, of all batches of Valium 5 mg tablets supplied in blister packs of 50 tablets as some blister packs contain paracetamol codeine tablets, BTC Rosuvastatin 10 mg tablets and Apotex-Pantoprazole 40 mg tablets.

If a patient has an affected pack, there is a risk that they will not have adequate supply of their medicine and could take the incorrect medicine, which could have serious health consequences.

The issue is being investigated in conjunction with the relevant authorities. However, it is believed that the tampering is not widespread for these particular products.

The TGA advises that anyone who takes Valpam 5 tablets supplied in 50 tablet blister packs should return any used or unused medicine to a pharmacy for a refund. In order to arrange an alternative medicine, consumers should speak with their pharmacist.

Please note that all tablets or capsules supplied in a pack should be identical and any product names on the blister packs should match those on the external packaging. If you notice any discrepancies, you should talk to your pharmacist immediately.

There is no evidence that other diazepam products are involved at this time.

If you have any other questions or concerns about this issue, talk to your health professional.